CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Call for Patient Input and Clinical Experts: Verkazia

Published on: April 23, 2019
Result type: News

CADTH has received the following notice(s) of pending drug submission(s).

Brand name Verkazia
Generic name cyclosporine
Manufacturer Santen Inc.
Indication(s) Severe vernal keratoconjunctivitis, pediatric (≥4 years)
Project Number SR0615-000
Call for patient input 2019-04-23
Patient input deadline 2019-06-12
Submit patient input Submit
Register as Clinical Expert Register